Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4725-4731, Vol. 67, No. 9
Department of Microbiology and Immunology,
The University of Oklahoma Health Sciences Center, Oklahoma City,
Oklahoma 73190,1 and Institute for
Molecular Biology, Jena University, D-07745 Jena,
Germany2
Received 23 February 1999/Returned for modification 12 May
1999/Accepted 17 June 1999
The CAMP reaction is a synergistic lysis of erythrocytes by the
interaction of an extracellular protein (CAMP factor) produced by some
streptococcal species with the Staphylococcus aureus
sphingomyelinase C (beta-toxin). Group A streptococci (GAS
[Streptococcus pyogenes]) have been long considered CAMP
negative, and this reaction commonly has been used to distinguish GAS
from Streptococcus agalactiae. We here provide evidence
that GAS possess this gene and produce an extracellular CAMP factor
capable of participating in a positive CAMP reaction. The S. pyogenes CAMP factor is specified by a 774-bp open reading frame
homologous to the CAMP factor genes from S. agalactiae and
Streptococcus uberis. This gene, designated
cfa, was isolated on a 1,256-bp fragment and cloned in
Escherichia coli. Recombinant clones of E. coli
expressing cfa secreted an active CAMP factor. The deduced
28.5-kDa protein encoded by cfa consists of 257 amino
acids, with a predicted 28-amino-acid signal peptide. The
cfa gene is widely spread among GAS: 82 of 100 clinical GAS
isolates produced a positive CAMP reaction. Of the CAMP-negative strains, 17 of the 18 GAS strains contained the cfa gene.
Additionally, CAMP activity was detected in streptococci from
serogroups C, M, P, R, and U. The cfa gene was cloned and
actively expressed in Escherichia coli and gene fusions
were made, placing the The CAMP reaction, as originally
described by Christie et al. (3), is the synergistic lysis
of sheep erythrocytes by Staphylococcus aureus
sphingomyelinase C (beta-toxin) and CAMP factor (cohemolysin), a
secreted 25.3-kDa protein from group B streptococci (GBS
[Streptococcus agalactiae]) (26). The CAMP
reaction consists of two sequential steps and is performed with
erythrocytes whose cell membranes contain at least 45 mol%
sphingomyelin (35, 41). The first step is the hydrolysis of
membrane sphingomyelin and phospholipids by the action of a
sphingomyelinase or phospholipase (5). In the second step,
the CAMP factor interacts nonenzymatically with the resulting
metastable membrane, commonly by binding of previously released
ceramide, leading to cell lysis (2, 5). Besides its role in
cohemolysis, the CAMP protein binds in a nonimmune reaction with the Fc
part of immunoglobulins G and M, leaving the Fab sites active
(17). Although the role of CAMP factor in pathogenesis is
unclear, several investigations suggest that the release of this
protein during systemic infections could impair the host immune
response. For example, rabbits receiving a single intravenous injection
of partially purified CAMP protein from GBS rapidly died. In mice, the
dose of the same protein had to be 45 times higher in relation to the
body mass for killing (32). However, mice that had received
prior injections of highly purified CAMP factor from GBS developed
fatal septicemia when infected intraperitoneally with sublethal doses
of GBS (17). These observations provide support for a
function of CAMP protein as a pathogenicity factor.
The CAMP factor genes of S. agalactiae (29),
Actinobacillus pleuropneumoniae (10), and
Streptococcus uberis (16) have been cloned and
expressed in Escherichia coli. The genes from S. agalactiae (cfb) (26) and S. uberis (cfu) (16) encode 28.4- and 28.3-kDa
proteins, respectively, with N-terminal signal peptides. The sequence
identity of the two CAMP factor proteins is 66.4%. A number of other
gram-positive and gram-negative bacteria are known to react positively
in the CAMP test, including Rhodococcus equi (9),
Pasteurella haemolytica (8), Listeria
monocytogenes, Listeria seeligeri (27),
Aeromonas sp. (7), certain Vibrio spp.
(18), and group G streptococci (34).
Group A streptococci (GAS) have long been considered CAMP negative.
Moreover, the CAMP reaction has been commonly used as a diagnostic test
for streptococci of serological group B and has been accepted as an
important way to differentiate GAS from GBS (4, 14, 24, 40).
Several reports have shown that GAS produce a positive CAMP reaction
under certain conditions, particularly anaerobic incubation (4,
14), but synergistic hemolysis seen in the CAMP reaction system
with GAS was interpreted as a false-positive reaction caused by small
amounts of unoxidized streptolysin O (38). Given this long
period of acceptance that GAS were CAMP negative, it was a surprise to
find in the sequence data of the Streptococcus pyogenes
SF370 genome sequencing project at the University of Oklahoma the
existence of a 774-bp open reading frame (ORF) with 67% identity to
the S. agalactiae cfb gene and with 65% identity to the
S. uberis cfu gene.
In this study, we demonstrate that GAS do possess and express the gene
for an active CAMP factor. Cloning in E. coli of the reading
frame homologous to the hitherto sequenced CAMP factor genes
demonstrates that it represents the gene designated cfa for
the CAMP factor of GAS. Using transcriptional-translational lacZ fusions, cfa promoter activity was studied
in both homologous and heterologous backgrounds. In S. pyogenes SF370, the highest level of activity of the
cfa promoter was observed during the early stationary phase
of growth.
Bacterial strains and culture conditions.
E. coli
JM109 (44) was used for cloning and expression studies.
S. pyogenes SF370 (36) was the source of
chromosomal DNA used for cloning of cfa and for
electrotransformation with plasmid DNA. Streptococcal strains surveyed
for CAMP activity were clinical isolates from the strain collection at
the University of Oklahoma. Staphylococcus aureus ATCC 25923 was used as the beta-toxin-producing test strain, and a clinical
S. agalactiae isolate (Children's Hospital, Oklahoma City,
Okla.) served as a positive control for the CAMP reaction. E. coli were grown in L broth medium (28), and
streptococcal strains were grown in Todd-Hewitt broth (Difco) supplemented with 0.2% yeast extract or on 5% sheep blood agar plates
(Fisher Scientific). For solid media, 1.5% Bacto Agar (Difco) was
added. Antibiotics were used in the following concentrations: for
E. coli, 500 mg of erythromycin per ml and 100 mg of
ampicillin per ml; for S. pyogenes, 3 mg of erythromycin per
ml. 5-Bromo-4-chloro-3-indolyl- Computer analysis.
The sequence of the chromosomal CAMP
factor gene was identified with BLASTX database searches (1,
13). Multiple sequence alignment of the CAMP factor genes from
S. pyogenes, S. agalactiae, and S. uberis was done with CLUSTALX (39). SignalP was used to
predict the probable signal peptide (23).
CAMP test.
Strains were tested for CAMP activity in a
conventional diffusion test with slight modification. In brief, the
test strains, and S. agalactiae as a positive control, were
streaked on 5% sheep blood agar plates perpendicular to, but not
touching, a streak of the beta-toxin-producing strain S. aureus ATCC 25923. After 12 to 20 h of incubation at 30°C,
streptococcal strains were inspected for CAMP hemolysis.
Recombinant DNA techniques and DNA primers.
All protocols
were performed as recommended by the manufacturers of the enzymes or by
standard methods (28). Chromosomal DNA was isolated from
S. pyogenes SF370 by the guanidium thiocyanate method
(25). Plasmid DNA was isolated with the QIAprep-spin plasmid
kit (Qiagen Inc.). PCRs were performed with Taq polymerase (Fisher Scientific); conditions were 30 cycles of 94°C (1 min), 37°C (1 min), and 72°C (2 min). The following oligonucleotides were
used as PCR primers: CAMP1 (5' GGAAATTAAAGAAATATTGACC),
CAMP2 (5' TCACCTCAAACTCTACAATGG), CAMP3 (5'
CCAAATTAAATCTTAAAAAGG), CAMP4 (5'
GGCGCCGGATCCTGTTTGGGTTTCATATTATTCCTC),
CAMP5 (5' TATGATTTTAGTTCAATTGG), CAMP6 (5'
CCAACCGCATGTGTGATAGCTTT), INT1 (5' AATCTAAAACAAAAAGCCCCACG), INT2 (5' AAAAAGGTTATTACAATTCACCA), and M13R (5' TCACACAGGAAACAGCTATGAC).
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Identification, Cloning, and Expression of the CAMP
factor gene (cfa) of Group A Streptococci
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-galactosidase gene (lacZ) under
control of the cfa promoter. These cfa
promoter-lacZ fusions were introduced into S. pyogenes via a bacteriophage-derived site-specific integration
vector where they showed that the cfa gene has a strong
promoter that may be subject to as-yet-unidentified regulatory factors.
The results presented here, along with previous reports, indicate that
the CAMP factor gene is fairly widespread among streptococci, being
present at least in groups A, B, C, G, M, P, R, and U.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-D-galactopyranoside (X-Gal) was used at a concentration of 40 mg/ml to detect
-galactosidase activity.
40 (5'
GTTTTCCCAGTCACGAC). Primers SP6 and T7 served for the sequencing
of PCR fragments cloned into pGEM-T Easy. The M13
40 primer was used
to ensure the accuracy of cfa-lacZ reporter fusions.
Sequencing was done with an ABI model 377 automated sequencer.
PCR analysis of cfa in CAMP-negative S. pyogenes strains. To detect the cfa gene in CAMP-negative S. pyogenes strains, DNA from crude cell lysates (15) was used as a template for PCR with primer pair CAMP4 and CAMP5 to amplify an internal 386-bp cfa fragment. For analysis, PCR products were separated on a 1.5% agarose gel.
Cloning and expression of the S. pyogenes cfa
gene.
To clone the cfa gene, PCR was performed with
S. pyogenes SF370 chromosomal DNA as a template. Fragments
generated with primers CAMP2 and CAMP3 (1,256 bp) containing
cfa with the complete promoter upstream region including the
3' end of the adjacent gene (see Fig. 1) were cloned into pGEM-T Easy
(Promega) to create pCAMP1 (Plac and
Pcfa in opposite orientations) and pCAMP2
(Plac and Pcfa in tandem
arrangement). Primers CAMP1 and CAMP2 generated a 992-bp fragment
containing cfa with only its core promoter. Cloning of this
fragment into pGEM-T Easy was possible only when spontaneous
cfa promoter down mutations occurred: pCAMP62 and pCAMP64,
both with Plac and cfa in the same
orientation, carried a T
C transition mutation in the
10 region and
a deletion of 30 nucleotides including the
35 promoter region,
respectively (see Fig. 1). In contrast, the 148-bp cfa core
promoter PCR fragment generated by primers CAMP1 and CAMP4 with pCAMP2
as the template was cloned into pGEM-T Easy to create pCAMP14. This
unstable plasmid has two vector fragments in opposite orientations
connected by two PCR fragments in the same orientation. Because of this
arrangement, pCAMP14 contained the cfa core promoter and
lacZ in the same orientation.
Construction of lacZ reporter fusions. The 3,072-bp BamHI fragment from pMC1871 (30) containing the 3' portion of lacZ starting with codon 10 was cloned into plasmid pPRG10 (12) digested with BamHI and BglII. The resulting plasmid, pPRGLAC (6.1 kb), contained the lacZ coding sequence from codon 10 with a BamHI site at its 5' end, the p15A origin of replication, and the ermAM erythromycin resistance gene selectable both in E. coli and S. pyogenes. Primers CAMP4 and M13R were used to amplify by PCR a 550-bp product from pCAMP2. This product was digested with BamHI and SalI, releasing a 436-bp digestion fragment containing the cfa promoter that was cloned into pPRGLAC to create pCAMP11 (6.5 kb), a vector containing a transcriptional and in-frame translational fusion of cfa to lacZ. The cfa-lacZ fusion plasmids pCAMP12, pCAMP13, and pCAMP16 were created by replacing the cfa portion of pCAMP11 with SalI-BamHI cfa promoter cassettes obtained by amplification of pCAMP62, pCAMP64, and pCAMP14, respectively, with the primer pair M13R and CAMP4. For the construction of cfa-lacZ fusion vectors capable of site-specific integration into the chromosome of S. pyogenes, PCR with primer pair INT1 and INT2 and p7INT, a derivative of pWM139 (20), as a template was performed. The resulting 1,802-bp fragment, containing the functional integrase gene and the phage attachment site from S. pyogenes bacteriophage T12 (21), was cloned into pGEM-T Easy. The integrase gene and attP were released from this construct by digestion with SphI and SalI and cloned into pCAMP11 digested with the same enzymes to create pCAMP17 (8.4 kb [see Fig. 5]). The 442-bp PstI-BamHI cfa promoter fragment of pCAMP17 was replaced by the 430- and 166-bp PstI-BamHI cfa promoter cassettes from pCAMP11 and pCAMP12, respectively, to create integration plasmids pCAMP18 (8.3 kb) and pCAMP19 (8.1 kb). Cloning of the cfa core promoter from pCAMP16 as a PstI-BamHI fragment in pCAMP17 was attempted repeatedly, but no stable constructs were obtained. Plasmids pCAMP18 and pCAMP19 were integrated into the chromosome of S. pyogenes SF370 following electroporation, as previously described (31). The 3' limit of the cfa portion on all reporter plasmids is cfa codon 4 fused in frame, via a BamHI site, to codon 10 of lacZ.
-Galactosidase assay.
-Galactosidase was assayed as
described previously (11), according to the method of Miller
(22). Fresh medium was inoculated with 10
2 and
10
3 volumes of overnight cultures of S. pyogenes and E. coli, respectively. Samples of E. coli were taken in the logarithmic growth phase (optical density
at 600 nm <1), and samples of S. pyogenes were taken in the
early logarithmic, late logarithmic, and early stationary growth
phases, which were experimentally determined by standard methods to
occur at about 2, 4, and 6 h of culture incubation. Cells were
harvested by centrifugation, resuspended, and made permeable to
o-nitrophenyl-
-D-galactopyranoside (ONPG) by
adding 20 µl of chloroform per sample and vortex mixing for 10 s.
-Galactosidase activity was determined at a temperature of 28°C
by measuring
E at 420 nm to detect
o-nitrophenyl released from ONPG and was calculated in
Miller units, proportional to enzyme activity per cell.
Nucleotide sequence accession number. The nucleotide sequence of cfa has been submitted to the EMBL/GenBank/DDBJ data banks and assigned accession no. AF079502.
| |
RESULTS |
|---|
|
|
|---|
The CAMP factor of GAS: native expression and sequence
analysis.
To determine whether the ORF with significant homology
to the CAMP factor genes from S. agalactiae (26)
and S. uberis (16) found in the course of
sequencing the genome of S. pyogenes SF370 (36)
actually encoded an active CAMP protein, this M1 strain was tested for
CAMP activity in a conventional diffusion test. CAMP activity was
detected, especially when incubation of the bacteria was done at 30°C
to limit the amount of hemolysis due to streptolysin activity, and the
ORF was considered the putative CAMP factor gene of group A
streptococci (cfa). Examination of the genome region
containing cfa revealed an ORF flanking cfa in
the 5' direction with the same orientation as cfa and
encoding a hypothetical protein that is homologous to bacterial amino
acid binding proteins (42). Another hypothetical ORF
neighboring cfa in the 3' direction and oriented oppositely
to cfa has homology to a number of hypothetical bacterial
proteins of unknown function (6). The intergenic regions
between the cfa coding sequence and neighboring ORFs in both
the 5' and 3' directions have lengths of 369 and 368 bp, respectively.
Putative cfa promoter
35 and
10 hexanucleotides
resembling E. coli
70 consensus promoter
sequences (19) were identified 101 and 78 bp upstream from
the cfa start codon. The 264-bp region upstream of position
50 of the putative cfa promoter (cfa promoter
upstream region; nucleotide positions 1 to 264 in Fig.
1a) contains inverted repeats of 11 and
10 bp. A potential Shine-Dalgarno sequence is located at an appropriate
distance from the ATG start codon of cfa. The coding
sequence of cfa consists of 774 nucleotides (35.7% G+C) and
encodes a 257-amino-acid protein with a molecular mass of 28.5 kDa and
a predicted N-terminal 28-amino-acid signal peptide. The identities of
the GAS CAMP factor with the homologous proteins from S. agalactiae (255 amino acids, 28.4 kDa) and S. uberis
(256 amino acids, 28.3 kDa) are 59.9 and 54.9%, respectively (Fig. 1b). Mature GAS CAMP factor is predicted to be a 25.5-kDa protein consisting of 229 amino acids.
|
Distribution of cfa among GAS. To investigate the general distribution of the cfa gene among GAS, 100 S. pyogenes strains of 60 different M types were surveyed in standard CAMP tests. Of these strains, 82 were CAMP positive. The level of CAMP factor production varied from strain to strain and ranged from a level similar to that produced by most GBS to completely negative (Fig. 2). PCR analysis of the 18 CAMP-negative strains with internal primers CAMP5 and CAMP6, and streptococcal chromosomal DNA as a template, revealed the existence of cfa in 17 of these strains. Only one isolate of S. pyogenes, originating from Canada (M31, T25), did not yield a cfa internal 386-bp fragment. The genes for CAMP proteins seem to be more common among streptococci than previously expected. CAMP tests also were performed with streptococci from serogroups other than A, and cohemolytic activity was found among isolates from streptococcal groups C, M, P, R, and U (not shown).
|
Cloning and expression of cfa in E. coli
JM109.
The cfa gene from S. pyogenes SF370
was cloned and expressed in E. coli JM109, resulting in
conversion of this recombinant strain to CAMP+ (Fig.
3). The amount of the promoter and
flanking upstream region cloned with the coding region had a strong
influence upon the level of CAMP expression in E. coli and
the stability of the recombinant plasmid. Plasmids pCAMP1 and pCAMP2,
which differed only in the orientation of the insert with respect to
the vector lacZ promoter, stably carried cfa, its
"core" promoter elements (i.e.,
10 and
35 regions), and the 5'
upstream region to the end of the neighboring 5' ORF (Fig. 1a).
However, attempted cloning by PCR of the sequence containing only the
cfa coding region and its core promoter yielded only 5% of
the expected number of recombinant clones, and all clones analyzed
carried mutations in the cfa promoter
10 or
35 element.
This instability of the native sequence in E. coli is not
related to vector copy number (not shown). The native promoter could be
cloned by including only the first four codons of the cfa
gene (pCAMP14). Two of these plasmids, pCAMP62 (T
C transition in the
10 hexanucleotide [TATGAT to TATGA
]) and
pCAMP64 (deletion of the
35 promoter region [Fig. 1a]), were chosen
for further investigation. On both plasmids, cfa was
oriented so that CAMP expression might be under the control of
Plac in E. coli. CAMP activity tests
performed with recombinant E. coli JM109 strains containing
plasmid pCAMP1, pCAMP2, pCAMP62, or pCAMP64 demonstrated production of an active CAMP factor in these strains; however, the
constructs differed in the amount of protein released (Fig. 3). The
highest level of CAMP activity, comparable to that found with the
positive control S. agalactiae, was produced by E. coli JM109 containing pCAMP62, followed by pCAMP64, pCAMP2, and
pCAMP1, which secreted the same amount of active CAMP protein as donor strain S. pyogenes SF370 (Fig. 3 and data not shown).
|
cfa promoter activity in E. coli and
S. pyogenes.
The different levels of CAMP activity detected
among GAS and the importance of the 264-bp cfa promoter 5'
upstream region for the stability of cfa clones in E. coli suggested that expression of cfa might be
regulated at the transcriptional level. To investigate cfa
expression and to determine the influence of the cfa
promoter upstream region on cfa promoter activity,
transcriptional-translational reporter fusions were made. These
fusions, containing the ribosome binding site and the first four codons
of cfa fused in frame with lacZ (from codon 10),
carried different cfa promoter constructs on a p15A replicon
in E. coli. Plasmid pCAMP11, shown in Fig. 4, has the core promoter and complete
cfa 5' upstream region. Plasmids pCAMP12, pCAMP13, and
pCAMP16 are identical to pCAMP11 except they derive their
cfa promoter regions from pCAMP62, pCAMP64, and
pCAMP14, respectively. The activity of the different cfa
promoter lacZ fusion constructs in E. coli JM109
during the logarithmic growth phase was determined by
-galactosidase assays, according to Miller (22).
E. coli JM109(pPRGLAC) was used as a negative control.
|
10 region or the
additional deletion of the
35 cfa promoter region resulted
in a 300-fold decrease of promoter activity (pCAMP12, 150 Miller units;
pCAMP13, 130 Miller units). The E. coli strains with the
different constructs grew equally well, and expression of the
CAMP-
-galactosidase fusion protein did not noticeably affect cell
viability (not shown).
|
C
transition in the
10 region) were cloned into pCAMP17 to create
pCAMP18 and pCAMP19, respectively. These cfa-lacZ fusion
constructs were introduced into S. pyogenes SF370, where the
phage T12 integrase specified by these plasmids mediated site-specific
integration of one copy of the plasmid at the attB site (not
shown). The resulting recombinant strains were tested for
-galactosidase activity in the early logarithmic (2 h), late logarithmic (4 h), and early stationary (6 h) growth phases. S. pyogenes SF370 containing p7INT, a plasmid containing only the T12
integrative elements and lacZ under the control of its
native promoter (20), was used as a negative control. The
results of the assays are shown in Fig. 5.
In the homologous host S. pyogenes SF370, the activity of
the cfa promoter with the native upstream region increased
10-fold during growth from early logarithmic to early stationary phase (pCAMP18, 39, 133, and 401 Miller units at the specified times). Deletion of the promoter upstream region and the single base pair exchange in the
10 region caused a dramatic decrease in
cfa promoter strength. The
-galactosidase activity
mediated by this promoter construct was only slightly above the values
determined for the negative control (p7INT) and decreased during growth
(pCAMP 19, 1.1, 0.9, and 0.7 Miller units).
| |
DISCUSSION |
|---|
|
|
|---|
The data presented in this paper demonstrate that, in contrast to the generally accepted view (4, 14, 24, 38, 40), S. pyogenes does possess the gene for an active CAMP factor protein. As shown by CAMP tests and by PCR analysis, the CAMP factor gene (cfa) is widespread among GAS. Of the 100 tested GAS strains, 82 gave a positive CAMP reaction. Among the 18 strains showing a CAMP-negative reaction, all but one contained at least part of the cfa gene, as shown by PCR amplification of a cfa internal fragment. The absence of CAMP factor expression among these 18 GAS strains was not clustered among any particular M serotype.
Cloning and expression of the cfa gene in recombinant E. coli strains confirms the existence of an active CAMP gene in GAS. Heterologous expression of the cfa gene demonstrated that the positive CAMP tests performed with different S. pyogenes strains were due to GAS CAMP protein and not to false-positive reactions, as assumed by Tapsall and Phillips (38). Indeed, the commonly accepted opinion that GAS are CAMP negative may have persisted over the years because of the relatively low level of CAMP activity produced by S. pyogenes. The level of secreted CAMP activity of tested GAS strains was in most cases clearly below the level produced by most GBS. Moreover, the clear zones caused by streptolysin often overlapped with the CAMP factor lysis zones, making clear identification of a positive CAMP reaction difficult (Fig. 4).
The CAMP reaction is temperature dependent between 15 and 30°C (35). Cooling of erythrocytes treated with S. aureus sphingomyelinase C to 4°C causes complete lysis of cells without the action of any CAMP-like protein (33). We performed CAMP tests at 30°C. At this temperature, the rate of CAMP factor induced-lysis is maximal, and erythrocyte membranes modified by sphingomyelinase C remain stable. Reduction of the temperature at which the CAMP tests were performed from 37 to 30°C resulted in sharper lysis zones and better identification of positive CAMP reactions.
The observed differences in CAMP production may be due to regulatory effects or to chromosomal alterations. The cfa promoter upstream region contains two distinct inverted repeats longer than 9 bp, of which the more upstream could act as a transcriptional terminator for the adjacent gene. The failure to clone cfa without this upstream region led us to the construction of transcriptional-translational cfa-lacZ fusions. They were used to study the influence of the native upstream region on cfa promoter activity and to investigate the expression of cfa during growth of the homologous host S. pyogenes SF370.
In E. coli, the presence of the native cfa
promoter upstream region reduces cfa promoter activity
significantly. The cfa core promoter exhibited an activity
of 40,700 Miller units (pCAMP16). Addition of the upstream region
decreased cfa promoter activity 1.9-fold (pCAMP11). Because
of the low-level activities measured for the mutated core promoters
(pCAMP12 and pCAMP13) a read-through from another promoter located on
the vector plasmid and a function of the region as a transcriptional
terminator can be excluded as a reason for this effect. Since E. coli is not the normal host, this reduction of promoter activity
may be due to steric properties of the cloned DNA and not to any
specific regulatory molecule. The high-level activity of the
cfa core promoter in pCAMP16 is comparable to that
determined for the promoter of the streptokinase gene (skc)
from S. equisimilis in E. coli (11).
The failure to clone the cfa core promoter without the
native upstream region in other plasmid constructions on ColE1 and p15A
replicons seems to be not due to toxicity of the gene products to the
host E. coli, but rather due to plasmid instabilities
induced by the activity of this strong promoter.
-Galactosidase
produced at high levels is not detrimental to E. coli
because of the formation of inclusion bodies (43).
The
35 and
10 cfa promoter sequences were detected by
their strong homology to the E. coli
70
consensus promoter sequences (19). In E. coli,
cfa promoter activity was reduced about 300-fold on plasmids
pCAMP12 and pCAMP13 carrying cfa promoter down mutations
resulting from a single base pair exchange in the putative
10
promoter region and deletion of the putative
35 promoter region,
respectively. These dramatic effects confirm the predicted location of
the cfa promoter.
When integrated into the S. pyogenes SF370 chromosome, the
transcriptional-translational cfa-lacZ fusion with a
mutation in the
10 region of the cfa promoter (pCAMP19)
released, depending upon growth phase, 35-fold to 570-fold less
-galactosidase activity than the lacZ fusion with the
native upstream region (pCAMP18). These results could therefore be
considered evidence for the lack of read-through from any promoter
located upstream. The level of cfa expression in S. pyogenes SF370::pCAMP18 increased 10-fold during growth
from the early logarithmic phase to the early stationary phase. This
activity corresponds to about 4 and 40%, respectively, of the activity
known for the promoter of the streptokinase gene (skc) in
S. equisimilis (11). The results of
-galactosidase assays suggest that GAS CAMP factor is produced at
the highest level when a limitation of nutrients occurs. Similarly to
these results, Takaisi-Kikuni et al. (37) detected in
S. agalactiae the maximal accumulation of CAMP factor in the
late logarithmic phase of growth.
Although the function of the CAMP protein as a cohemolytic agent is well characterized, the common distribution of the genes among streptococci and the variable expression levels of CAMP genes in GAS suggest that these factors may fulfill another, more substantial function in physiology or pathogenicity. As demonstrated by Jürgens et al. (17), one additional function of CAMP factor from GBS is the nonspecific binding to immunoglobulins, thus impairing the immune response of the host. Further investigations might better define the potential role of CAMP factor proteins in pathogenesis of streptococci.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grants AI19304 and AI38406 from the National Institutes of Health to J.J.F.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: BMSB 1053, University of Oklahoma Health Sciences Center, 940 S. L. Young Blvd., Oklahoma City, OK 73013. Phone: (405) 271-1202. Fax: (405) 271-3117. E-mail: William-McShan{at}ouhsc.edu.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[Medline]. |
| 2. |
Bernheimer, A. W.,
R. Linder, and L. S. Avigad.
1979.
Nature and mechanism of action of the CAMP protein of group B streptococci.
Infect. Immun.
23:838-844 |
| 3. | Christie, R., N. E. Atkins, and E. Munch-Petersen. 1944. A note on a lytic phenomenon shown by group B streptococci. Aust. J. Exp. Biol. 22:197-200. |
| 4. |
Darling, C. L.
1975.
Standardization and evaluation of the CAMP reaction for the prompt, presumptive identification of Streptococcus agalactiae (Lancefield group B) in clinical material.
J. Clin. Microbiol.
1:171-174 |
| 5. | Fehrenbach, F. J., D. Jürgens, J. Rühlmann, B. Sterzik, and M. Özel. 1988. Role of CAMP factor (protein B) for virulence, p. 351-357. In F. J. Fehrenbach, J. E. Alouf, P. Falmagne, W. Goebel, J. Jeljaszewicz, D. Jürgens, and R. Rappuoli (ed.), Bacterial protein toxins. Gustav Fischer Verlag, Stuttgart, Germany. |
| 6. | Ferson, A. E., L. V. J. Wray, and S. H. Fisher. 1996. Expression of the Bacillus subtilis gabP gene is regulated independently in response to nitrogen and amino acid availability. Mol. Microbiol. 22:693-701[Medline]. |
| 7. |
Figura, N., and P. Guglielmetti.
1987.
Differentiation of mobile and mesophilic Aeromonas strains into species by testing for a CAMP-like factor.
J. Clin. Microbiol.
25:1341-1342 |
| 8. | Fraser, G. 1962. The hemolysis of animal erythrocytes by Pasteurella haemolytica produced in conjunction with certain staphylococcal toxins. Res. Vet. Sci. 3:104-110. |
| 9. | Fraser, G. 1961. Hemolytic activity of Corynebacterium ovis. Nature (London) 189:246[Medline]. |
| 10. |
Frey, J.,
J. Perrin, and J. Nicolet.
1989.
Cloning and expression of a cohemolysin, the CAMP factor of Actinobacillus pleuropneumoniae.
Infect. Immun.
57:2050-2056 |
| 11. | Gase, K., T. Ellinger, and H. Malke. 1995. Complex transcriptional control of the streptokinase gene of Streptococcus equisimilis H46A. Mol. Gen. Genet. 247:749-758[Medline]. |
| 12. | Gase, K., A. Gase, H. Schirmer, and H. Malke. 1996. Cloning, sequencing and functional overexpression of the Streptococcus equisimilis H46A gapC gene encoding a glyceraldehyde-3-phosphate dehydrogenase that also functions as a plasmin(ogen)-binding protein. Purification and biochemical characterization of the protein. Eur. J. Biochem. 239:42-51[Medline]. |
| 13. | Gish, W., and D. J. States. 1993. Identification of protein coding regions by database similarity search. Nat. Genet. 3:266-272[Medline]. |
| 14. |
Gubash, S. M.
1978.
Synergistic hemolysis phenomenon shown by an alpha-toxin-producing Clostridium perfingens and streptococcal CAMP factor in presumptive streptococcal grouping.
J. Clin. Microbiol.
8:480-488 |
| 15. | Hynes, W. L., J. J. Ferretti, M. S. Gilmore, and R. A. Segarra. 1992. PCR amplification of streptococcal DNA using crude cell lysates. FEMS Microbiol. Lett. 73:139-142[Medline]. |
| 16. | Jiang, M., L. A. Babiuk, and A. A. Potter. 1996. Cloning, sequencing and expression of the CAMP factor gene of Streptococcus uberis. Microb. Pathog. 20:297-307[Medline]. |
| 17. |
Jürgens, D.,
B. Sterzik, and F. J. Fehrenbach.
1987.
Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity.
J. Exp. Med.
165:720-732 |
| 18. | Köhler, W. 1988. CAMP-like phenomena of vibrios. Zentbl. Bakteriol. Hyg. A 270:35-40. |
| 19. | McClure, W. R. 1985. Mechanism and control of transcription initiation in procaryotes. Annu. Rev. Biochem. 54:171-204[Medline]. |
| 20. | McShan, W. M., R. E. McLaughlin, A. Nordstrand, and J. J. Ferretti. 1998. Vectors containing streptococcal bacteriophage integrases for site-specific gene insertion. Methods Cell Sci., in press. |
| 21. | McShan, W. M., Y.-F. Tang, and J. J. Ferretti. 1997. Bacteriophage T12 of Streptococcus pyogenes integrates into the gene encoding a serine tRNA. Mol. Microbiol. 23:719-728[Medline]. |
| 22. | Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Plainview, N.Y. |
| 23. |
Nielsen, H.,
J. Engelbrecht,
S. Brunak, and G. von Heijne.
1997.
Identification of procaryotic and eucaryotic signal peptides and prediction of their cleavage sites.
Protein Eng.
10:1-6 |
| 24. |
Phillips, E. A.,
J. W. Tapsall, and D. D. Smith.
1980.
Rapid tube CAMP test for identification of Streptococcus agalactiae (Lancefield group B).
J. Clin. Microbiol.
12:135-137 |
| 25. | Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-156. |
| 26. | Podbielski, A., O. Blankenstein, and R. Lütticken. 1994. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med. Microbiol. Immunol. 183:239-256[Medline]. |
| 27. |
Rocourt, J., and P. A. D. Grimont.
1983.
Listeria welshimeri sp. nov. and Listeria seeligeri sp. nov.
Int. J. Syst. Bacteriol.
33:866-869 |
| 28. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 29. |
Schneewind, O.,
K. Friedrich, and R. Lütticken.
1988.
Cloning and expression of the CAMP factor of group B streptococci in Escherichia coli.
Infect. Immun.
56:2174-2179 |
| 30. | Shapira, S. K., J. Chou, F. V. Richaud, and M. J. Casadaban. 1983. New versatile plasmid vectors for expression of hybrid proteins coded by a cloned gene fused to lacZ gene sequences encoding an enzymatically active carboxy-terminal portion of beta-galactosidase. Gene 25:71-82[Medline]. |
| 31. | Simon, D., and J. J. Ferretti. 1991. Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol. Lett. 82:219-224. |
| 32. |
Skalka, B., and J. Smola.
1981.
Lethal effect of CAMP-factor and UBERIS-factor a new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis.
Zentbl. Bakteriol.
249:190-194.
|
| 33. |
Smyth, C. J.,
R. Mollby, and T. Wadstrom.
1975.
Phenomenon of hot-cold hemolysis: chelator-induced lysis of sphingomylinase-treated erythrocytes.
Infect. Immun.
12:1104-1111 |
| 34. | Soedermanto, I., and C. Lämmler. 1996. Comparative studies on streptococci of serological group G isolated from various origins. Zentbl. Vet. Reihe B 43:513-523. |
| 35. |
Sterzik, B., and F. J. Fehrenbach.
1985.
Reaction componenets influencing CAMP factor induced lysis.
J. Gen. Microbiol.
131:817-820 |
| 36. | Suvorov, A. N., and J. J. Ferretti. 1995. A physical and genetic map of an M type 1 strain of Streptococcus pyogenes. Dev. Biol. Stand. 85:215-218[Medline]. |
| 37. | Takaisi-Kikuni, N. B., D. Jürgens, J. Wecke, and F. J. Fehrenbach. 1997. Immunochemical localization of CAMP factor (protein B) in Streptococcus agalactiae. Microbios 89:171-185[Medline]. |
| 38. |
Tapsall, J. W., and E. A. Phillips.
1984.
Streptococcus pyogenes streptolysin O as a cause of false-positive CAMP reactions.
J. Clin. Microbiol.
19:534-537 |
| 39. |
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 40. |
Wilkinson, H. W.
1977.
CAMP-disk test for presumptive identification of group B streptococci.
J. Clin. Microbiol.
6:42-45 |
| 41. | Wiseman, G. M., and J. D. Caird. 1967. The nature of staphylococcal beta hemolysin. I. Mode of action. Can. J. Microbiol. 13:369-376[Medline]. |
| 42. |
Wissenbach, U.,
B. Keck, and G. Unden.
1993.
Physical map location of the new artPIQMJ genes of Escherichia coli, encoding a periplasmatic arginine transport system.
J. Bacteriol.
175:3687-3688 |
| 43. | Worrall, D. M., and N. H. Goss. 1989. The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust. J. Biotechnol. 3:28-32[Medline]. |
| 44. | Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»